Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
02 May 2014 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Two HPV Vaccines Cancer prevention - Gynaecologic malignancies - Gastrointestinal cancers
30 Apr 2014 The Role of Postoperative Radiation Therapy for Endometrial Cancer Gynaecologic malignancies
29 Apr 2014 EMA Recommends Granting a Marketing Authorisation for Trametinib and Extending Indications for Sorafenib Melanoma - Endocrine cancers - Anticancer agents & Biologic therapy
28 Apr 2014 EORTC and SIOG Update Expert Opinion on Management of Elderly Patients with NSCLC Cancer in Special Situations - Lung and other thoracic tumours
25 Apr 2014 Recommendations for a Molecular Diagnostics Curriculum Personalised medicine - Bioethics, legal and economic issues - Translational research
24 Apr 2014 Biomarker Enrichment Strategies Personalised medicine - Translational research
23 Apr 2014 FDA Approves Ramucirumab for Gastric Cancer or Gastroesophageal Junction Adenocarcinoma Gastrointestinal cancers
22 Apr 2014 European Medicines Agency Alerts EU Healthcare Professionals After Vials of Falsified Anti-Cancer Medicines Identified Bioethics, legal and economic issues - Anticancer agents & Biologic therapy
18 Apr 2014 Does a More Refined Categorisation of Tumour Response and/or Progression Improve Prediction of Overall Survival in RECIST 1.1? Anticancer agents & Biologic therapy
17 Apr 2014 European Medicines Agency and EU National Competent Authorities Agree on Action Plan to Address Medication Errors Bioethics, legal and economic issues
16 Apr 2014 In-depth Focus on Effective Cancer Control and Care in China, India, and Russia Cancer prevention
15 Apr 2014 A Meta-Analysis of First Generation EGFR TKIs vs. Chemotherapy in Patients with Wild Type EGFR Non-Small Cell Lung Cancer Lung and other thoracic tumours - Anticancer agents & Biologic therapy
14 Apr 2014 A Subset of Breast Cancer Patients Most Likely to Benefit From Neoadjuvant Regimen With Pan-HER Inhibitor Neratinib Breast cancer - Anticancer agents & Biologic therapy
11 Apr 2014 HPV as a Primary Screening Tool in Women 25 Years and Older for Risk Assessment of Cervical Cancer Cancer prevention - Gynaecologic malignancies
10 Apr 2014 No Prognostic Effect of HPV on the Outcome of Primary Radiotherapy in Advanced Non-Oropharyngeal Cancers Head and neck cancers